Micromet Articles

72% complete response in Ph II leukemia study of Amgen's blinatumomab

21 May 2012

Amgen says tender offer for Micromet on track

4 March 2012

Amgen to acquire US/German biotech firm

27 January 2012

Highlights of ASH meeting

13 December 2011

Amgen in up to 695 million-euro BiTE antibody deal with Micromet

12 July 2011

Chelsea and Micromet leap on strong clinical data for Northera and blinatumomab

13 June 2011

Bayer aims to raise its profile, focusing on umbrella brand and dropping Schering name; pays milestone in Micromet deal

9 November 2010

Bayer taps ex-Novartis COO as new head of health care unit; pays milestone to Micromet in antibody collaboration

22 April 2010

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end